Summary
Cardiovascular disease is the single largest cause of death in the elderly. Many of the published studies concerning the physiology and pharmacology of the aging cardiovascular system are seriously flawed. Problems include failure to measure the drug bioavailability and the selection of subjects with overt or subclinical disease.
With exercise, the rise in heart rate is inversely proportional to age and maximum heart rate is reduced. Baroreceptor reflex activity appears to decline with age. Cardiac output is maintained in the elderly, with a slower heart rate and a greater stroke volume than in the young.
Plasma noradrenaline (norepinephrine) levels increase in the elderly but there is no change in the sensitivity of the vasoconstrictor α1-adrenoceptor. There is evidence for a decline in the activity of the vasodilator β 2-adrenoceptor with age.
It is difficult to make general rules about the effect of aging on the disposition and elimination of drugs. Each drug must be tested separately.
Similar content being viewed by others
References
Abrass IB, Scarpace PJ. Human lymphocyte beta-adrenergic receptors are unaltered with age. Journal of Gerontology 36: 298–301, 1981
Andreasen F, Hansen U, Husted SE, Jansen JA. The pharmacokinetics of frusemide are influenced by age. British Journal of Clinical Pharmacology 16: 391–397, 1983
Andreasen F, Hansen U, Husted SE, Mogensen CE, Pedersen EB. The influence of age on renal and extrarenal effects of frusemide. British Journal of Clinical Pharmacology 18: 65–74, 1984
Aronson JK, Grahame-Smith DG. Monitoring digoxin therapy: II. Determinants of the apparent volume of distribution. British Journal of Clinical Pharmacology 4: 223–227, 1977
Bender AD. Effect of age on intestinal absorption: implications for drug absorption in the elderly. Journal of the American Geriatrics Society 16: 1331–1339, 1968
Bennett T. Cardiovascular responses to central hypovolaemia in man: physiology and pathophysiology. Physiologist 30: S143–S146, 1987
Bertel O, Landemann R, Lutold BE, Bolli P. Plasma catecholamines and cardiac renal and peripheral vascular adrenoceptor mediated responses in different age groups in normal and hypertensive subjects. Clinical and Experimental Hypertension 2: 409–426, 1980
Borhani NO. Isolated systolic hypertension in the elderly. Journal of Hypertension 6: SI5–S19, 1988
Brandfonbrener M, Landowne M, Shock NW. Changes in cardiac output with age. Circulation 12: 557–566, 1955
Brodde O-E, Anlauf M, Graben N, Bock KD. Age-dependent decrease of alpha-2-adrenergic receptor number in human platelets. European Journal of Pharmacology 81: 345–347, 1982
Buhler FR. Age and cardiovascular response adaptation: determinants of an antihypertensive treatment concept primarily based on beta-blockers and calcium entry blockers. Hypertension 94 (Suppl. III): 94–98, 1983
Caird FI, Scott PJW. Drug induced diseases in the elderly. Elsevier, Amsterdam, 1986
Castleden CM, George CF. The effect of ageing on the hepatic clearance of propranolol. British Journal of Clinical Pharmacology 7: 49–54, 1979
Castleden CM, George CF. Prescriptions for the elderly. In O’Malley K (Ed.) Clinical pharmacology and drug treatment in the elderly, pp. 71–98, Churchill Livingstone, Edinburgh, 1984
Conway J, Wheeler R, Sannerstedt R. Sympathetic nervous activity during exercise in relation to age. Cardiovascular Research 5: 577–581, 1971
Christensen NJ. Sympathetic nervous activity and age. European Journal of Clinical Investigation 12: 91–92, 1982
Cusack B, Horgan J, Kelly JG, Lavan J, Noel J, et al. Digoxin in the elderly: pharmacokinetic consequences of old age. Clinical Pharmacology and Therapeutics 25: 772–776, 1979
Dambrink JHA, Wieling W. Circulatory response to postural change in healthy male subjects in relation to age. Clinical Science 72: 335–341, 1987
Davies DF, Shock NW. Age changes in glomerular filtration rate, effective renal plasma flow, and tubular excretory capacity in adult males. Journal of Clinical Investigation 29: 496–507, 1950
Davis D, Grossman SH, Kitchell BB, Shand DG, Routledge PA. The effects of age and smoking on the plasma protein binding of lignocaine and diazepam. British Journal of Clinical Pharmacology 19: 261–265, 1985
Davis PB, Silski C. Ageing and the alpha-2-adrenergic system of the platelet Clinical Science 73: 507–13, 1987
Ebert TJ, Hughes CV, Tristani FE, Barney JA, Smith JJ. The effect of age and coronary heart disease on the circulatory response to graded lower body negative pressure. Cardiovascular Research 16: 663–669, 1982
Elfellah MS, Dalling R, Kantola IM, Reid JL. Beta-adrenoceptors and human skeletal muscle characterisation of receptor subtype and effect of age. British Journal of Clinical Pharmacology 27: 31–38, 1989
Elliott HL, Sumner DJ, McLean K, Reid JL. Effect of age on the responsiveness of vascular alpha-adrenoceptors in man. Journal of Cardiovascular Pharmacology 4: 388–392, 1982
Esler M, Skews H, Leonard P, Jackman G, Bobik A, et al. Age-dependence of noradrenaline kinetics in normal subjects. Clinical Science 60: 217–219, 1981
Erne P, Bolli P, Bertel O, Hulthen UL, Kiowski W, et al. Factors influencing the hypotensive effects of calcium antagonists. Hypertension 5 (Suppl. II): 97–102, 1983
Evans MA, Triggs EJ, Cheung M, Broe GA, Creasey H. Gastric emptying rate in the elderly: implications for drug therapy. Journal of the American Geriatrics Society 29: 201–205, 1981
Ewy GA, Kapadia GC, Yao L, Lullin M, Marcus FI. Digoxin metabolism in the elderly. Circulation 39: 449–453, 1969
Fulton J, MacDonald E, McDonald A, Scott PJW, Wadsworth R. Contractile responsiveness of the aged human isolated mesenteric artery. Journal of Physiology (London) 392: 86P, 1987
Geokas MC, Haverback BJ. The aging gastrointestinal tract. American Journal of Surgery 117: 881–892, 1969
Gerstenblith G. Noninvasive assessment of cardiac function in the elderly. In Weisfeldt JL (Ed.) The aging heart, Aging Vol. 12, pp. 247–267, Raven Press, New York, 1980
Gribben B, Pickering TG, Sleight P, Peto R. Effect of age and high blood pressure on baroreflex sensitivity in man. Circulation Research 29: 424–431, 1971
Hervonen A, Vaalastic A, Partanen M, Kanerva L, Hervonen H. Effects of aging on the histochemically demonstrable catecholamines and acetylcholinesterase of human sympthetic ganglia. Journal of Neurocytology 7: 11–20, 1978
Hockings N, Ajayi AA, Reid JL. Age and the pharmacokinetics of angiotensin converting enzyme inhibitors enalapril and enalaprilat. Britih Journal of Clinical Pharmacology 21: 341–348, 1986
Hodkinson M. Clinical biochemistry of the elderly, Churchill Livingstone, Edinburgh, 1984
Holford NHG, Sheiner LB. Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models. Clinical Pharmacokinetics 6: 429–453, 1981
Hyland L, Docherty JR. An investigation of age-related changes in pre- and postjunctional alpha-adrenoceptors in human saphenous vein. European Journal of Pharmacology 114: 361–364, 1985
Kannel WB, Wolf PA, McGee DL, Dawber TR, Mcnamara P, et al. Systolic blood pressure, arterial rigidity and risk of stroke: the Framingham Study. Journal of the American Medical Association 245: 1225–1229, 1981
Kendall MJ, Woods KL, Wilkins MR, Worthington DJ. Responsiveness to beta-adrenergic stimulation: the effects of age are cardioselective. British Journal of Clinical Pharmacology 14: 821–826, 1982
Kelliher GJ, Conahan ST. Changes in vagal activity and response to muscarinic receptor agonists with age. Journal of Gerontology 35: 842–849, 1980
Lakatta EG. Diminished beta-adrenergic modulation of cardiovascular function in advanced age. Cardiology Clinics 4: 185–200, 1986
Lakatta EG. Cardiac muscle changes in sensecence. Annual Review of Physiology 49: 519–531, 1987
MacGilchrist J, Hawksby C, Howes LG, Reid JL. Rise in plasma noradrenaline with age results from an increase in spillover rate. Gerontology 35: 7–13, 1989
MacLennan WJ. Diuretics in the elderly: how safe? British Medical Journal 296: 1551, 1988
MacLennan WJ, Hall MRP, Timothy JL. Postural hypotension in old age: is it a disorder of the nervous system or of blood vessels? Age and Aging 9: 25–32, 1980
Mancia G, Grassi G, Ferrari A, Zanchetti A. Reflex cardiovascular regulation in humans. Journal of Cardiovascular Pharmacology 7 (Suppl. 3): 152–159, 1985
Nakamura M, Ogihara T, Higaki J, et al. Effect of age on active and inactive plasma renin in normal subjects and in patients with essential hypertension. Journal of American Geriatrics Society 29: 379–382, 1981
Novak LP. Ageing, total body potassium, fat-free mass and cell mass in males and females between 18 and 85 years. Journal of Gerontology 27: 438–444, 1972
Oimomi M, Hatanaka H, Maeda Y, Hata F, Kitamura Y, et al. Autonomic nervous function determined by changes of periflux blood flow in the aged. Archives of Gerontology and Geriatrics 5: 159–163, 1986
Palmer GJ, Zeigler MG, Lake CR. Response of norepinephrine and blood pressure to stress with age. Journal of Gerontology 33: 482–487, 1978
Pan HYM, Hoffman BB, Pershe RA, Blaschke TF. Decline in beta adrenergic receptor-mediated vascular relaxation with aging in man. Journal of Pharmacology and Experimental Therapeutics 239: 802–807, 1986
Poehlman ET, McAuliffe T, Danforth E. Effects of age and level of physical activity on plasma norepinephrine kinetics. American Journal of Physiology 258: 356–362, 1990
Reid JL. Angiotensin converting enzyme inhibitors in the elderly. British Medical Journal 295: 943–944, 1987
Roberts MA, Caird FI. Steady state kinetics of digoxin in the elderly. Age and Ageing 5: 214–223, 1976
Robertson DRC, Waller DG, Renwick AG, George CF. Age-related changes in the pharmacokinetics and pharmacodynamics of nifedipine. British Journal of Clinical Pharmacology 25: 297–305, 1988
Robinson S. Experimental studies of physical fitness in relation to age. Arbeitsphysiologie 10: 251–323, 1938
Rodeheffer RJ, Gerstenblith G, Becker LC, Fleg JL, Weisfeldt M, et al. Exercise cardiac output is maintained with advancing age in healthy human subjects: cardiac dilatation and increased stroke volume compensate for decreased heart rate. Circulation 69: 203–213, 1984
Rubin PC, Scott PJW, McLean K, Pearson AW, Ross D, et al. Atenolol disposition in young and elderly subjects. British Journal of Clinical Pharmacology 13: 235–237, 1982a
Rubin PC, Scott PJW, McLean K, Reid JL. Plasma noradrenaline and clearance in relation to age and blood pressure in man. European Journal of Clinical Investigation 12: 121–125, 1982b
Rubin PC, Scott PJW, Reid JL. Prazosin disposition in young and elderly subjects. British Journal of Clinical Pharmacology 12: 401–404, 1981
Sato T, Miwa T, Tauchi H. Age changes in the human liver of different races. Gerontologia 16: 368–380, 1970
Scarpace PJ, Turner N, Mader L. β-Adrenergic function in aging: basic mechanisms and clinical implications. Drugs & Aging 1: 116–129, 1991
Schneider RE, Bishop H, Yates RA, Quaterman CP, Kendall MJ. Effect of age on plasma propranolol levels. British Journal of Clinical Pharmacology 10: 169–170, 1980
Schneider RE, Frohlich ED, Messerli FH. Pathophysiology of hypertension in the elderly. Cardiology Clinics 4: 235–243, 1986
Scott PJW, Hosie J, Scott MGB. A double-blind and cross-over comparison of once daily doxazosin and placebo with steady-state pharmacokinetics in elderly hypertensive patients. European Journal of Clinical Pharmacology 34: 119–123, 1988
Scott PJW, Reid JL. The effect of age on the responses of human isolated arteries to noradrenaline. British Journal of Clinical Pharmacology 13: 237–239, 1982
Shepherd AMM, Hewick DS, Moreland TA, Stevenson IH. Age as a determinant of sensitivity to warfarin. British Journal of Clinical Pharmacology 4: 315–320, 1977
Sherlock, Bearn AG, Billing BG, Paterson JCS. Splanchnic blood flow in man by the bromosulfalein method: the relation of peripheral plasma bromosulfalein level to the calculated flow. Journal of Laboratory and Clinical Medicine 35: 923–932, 1950
Shimada K, Kitazumi T, Sadakane N, Ogura H, Ozawa T. Age-related changes of baroreflex function, plasma norepinephrine and blood pressure. Hypertension 7: 113–117, 1985
Shock NW, Watkin DM, Yiengst MJ, et al. Age differences in the water content of the body as related to basal oxygen consumption in males. Journal of Gerontology 18: 1–8, 1963
Simpson DM, Wicks R. Spectral analysis of heart rate indicates reduced baroreceptor-related heart rate viability in elderly persons. Journal of Gerontology 43: M21–M24, 1988
Stevens MJ, Lipe S, Moulds RWF. The effect of age on the responses of human isolated arteries and veins to noradrenaline. British Journal of Clinical Pharmacology 14: 750–752, 1982
Tuck ML, Williams GH, Cain JP, Sullivan JM, Dluhy RG. Relation of age, diastolic pressure and known duration of hypertension to presence of low renin essential hypertension. American Journal of Cardiology 32: 637–642, 1973
van Brummelen P, Buhler FR, Kiowski W, Amann FW. Age-related decrease in cardiac and peripheral vascular responsiveness to isoprenaline; studies in normal subjects. Clinical Science 60: 571–577, 1981
Veering BT, Burm AGL, Souverijn JHM, Serree JMP, Spierdijk J. The effect of age on serum concentrations of albumin and alpha-1-acid glycoprotein. British Journal of Clinical Pharmacology 29: 201–206, 1990
Veith RC, Featherstone JA, Linares OA, Halter JB. Age differences in plasma norepinephrine kinetics in humans. Journal of Gerontology 41: 319–324, 1986
Vestal RE, Wood AJJ, Shand DG. Reduced beta-adrenoceptor sensitivity in the elderly. Clinical Pharmacology and Therapeutics 26: 181–186, 1979
Vokonas PS, Kannel WB, Cupples LA. Epidemiology and risk of hypertension in the elderly: the Framingham Study. Journal of Hypertension 6 (Suppl. 1): 3–9, 1988
Wallin BG, Sundlof G, Eriksson B-M, Dominiak P, Grobecker H, et al. Plasma noradrenaline correlates to sympathetic muscle nerve activity in normotensive man. Acta Physiologica Scandinavica 111: 69–73, 1981
Weidman P, Myttenaere-Bursztein S, Maxwell MH, Lima J. Effect of aging on plasma renin and aldosterone in normal man. Kidney International 8: 325–333, 1975
Williams BO, Caird FI, Lennox IM. Haemodynamic response to postural stress in the elderly with and without postural hypotension. Age and Ageing 14: 193–201, 1985
Williams PEO, Brown AN, Rajaguru S, Walters GE, McEwen J, et al. A pharmacokinetic study of cilazapril in elderly and young volunteers. British Journal of Clinical Pharmacology 27: 211S–216S, 1989
Williamson J, Chopin JM. Adverse reactions of prescribed drugs: a multicentre investigation. Age and Ageing 9: 73–80, 1980
Wolinsky H. Long term effects of hypertension on the rat aortic wall and their relation to concurrent aging changes. Circulation Research 30: 301–309, 1972
Wood AJJ, Feely J. Management of hypertension in the elderly. Southern Medical Journal 74: 1503–1508, 1981
Wood M. Plasma drug binding: implications for anesthesiologists. Anesthesiology and Analgesia 65: 786–804, 1986
Woodhouse KW, Mutch E, Williams FM, Rawlins MD, James OFW. The effect of age on pathways of drug metabolism in the human liver. Age and Ageing 13: 328–334, 1984
Yokoyama M, Kusui A, Sakamoto S, Fukuzaki H. Age-associated increments in human platelet alpha-adrenoceptor capacity: possible mechanism for platelet hyperactivity to epinephrine in aging man. Thrombosis Research 34: 287–295, 1984
Zeigler MG, Lake CR, Kopin IJ. Plasma noradrenaline increases with age. Nature 261: 333–335, 1976
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Stolarek, I., Scott, P.J.W. & Caird, F.I. Physiological Changes Due to Age. Drugs & Aging 1, 467–476 (1991). https://doi.org/10.2165/00002512-199101060-00006
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002512-199101060-00006